hat
Loris HCL fonksyon dwòg kontwole metabolis ak apeti. Dwòg la te apwouve pa FDA nan ane a 2012 pou moun ki gen yon BMI nan plis pase 30, ak pou pasyan ki gen yon Index Mass Kò nan 27 oswa plis ki gen tou kolestewòl, san presyon, ak kalite 2 dyabèt. Dwòg la tou fonksyone amelyore reseptè a serotonin 2CV nan sèvo imen an ki ka ede pasyan yo santi yo plen apre yo fin pran mwens.
eng
Lorcaserin HCl drug functions to control metabolism and appetite. The drug was approved by the FDA in the year 2012 for people with a BMI of more than 30, and for patients with a Body Mass Index of 27 or more who also have high cholesterol, blood pressure, and type 2 diabetes. The drug also functions to enhance the serotonin 2CV receptor in the human brain that can assist patients to feel full after taking less.